Pediatric Therapeutics and Diagnostics Solutions sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Pediatric Therapeutics and Diagnostics Solutions
1.1 - About Pediatric Therapeutics and Diagnostics Solutions sector
Companies in the Pediatric Therapeutics and Diagnostics Solutions category develop and commercialize pediatric-focused drugs, devices, diagnostic tests, and digital tools designed for infants, children, and adolescents. They deliver value by tailoring formulations, instrumentation, and care pathways to pediatric physiology, enabling earlier detection, safer treatment, and standardized workflows across children’s hospitals and health systems, while supporting regulatory compliance and evidence generation for pediatric indications.
Typical offerings include pediatric formulations with age-appropriate dosing and drug delivery systems, neonatal and pediatric medical devices such as ventilators, infusion pumps, and monitoring sensors, molecular and serology diagnostics for newborn screening and infectious diseases, genetic testing and sequencing for rare disorders, pediatric vaccines and immunization program support, clinical decision support embedded in EHRs, remote patient monitoring and telehealth, and specialized clinical trial services and biostatistics for pediatric populations.
These companies primarily serve children’s hospitals and health systems, pediatric clinics and medical groups, and biopharma organizations pursuing pediatric indications. Customers achieve earlier diagnosis through targeted assays, reduced adverse events via weight-based dosing and device safety features, faster study start-up and enrollment in pediatric trials, improved care coordination with EHR decision support, and stronger reimbursement and regulatory alignment for child health products.
2. Buyers in the Pediatric Therapeutics and Diagnostics Solutions sector
2.1 Top strategic acquirers of Pediatric Therapeutics and Diagnostics Solutions companies
Owlet
- Description: Provider of modern parenting technology offering the first FDA-cleared smart baby monitor and a connected nursery ecosystem that delivers trusted health insights when parents need them most.
- Key Products:
- Smart Baby Monitor & Connected Nursery Ecosystem: FDA-cleared monitor integrated with nursery ecosystem, providing real-time trusted health insights to parents for safer, more informed caregiving
- BabySat FDA-Cleared Baby Monitor: Stand-alone FDA-cleared baby monitor designed to track infants’ health status, giving parents confidence through compliant, reliable monitoring technology.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Pediatric Therapeutics and Diagnostics Solutions sector
M&A buyer group 1: Diversified Pharmaceuticals
Lilly
- Type: N/A
- Employees: ●●●●●
- Description: Provider of pharmaceutical medicines, diagnostics and patient-support services addressing chronic conditions worldwide, offering LillyDirect home delivery with savings support, condition resources, telehealth and well-being content, underpinned by 150 years of science-driven drug development.
- Key Products:
- Medicines Portfolio: Collection of nearly 100 high-quality pharmaceutical medicines created to meet real patient needs and improve health outcomes globally through evidence-based innovation
- Pharmaceutical Research & Discovery: Continuous research programs that drive new medicine development, leveraging 145+ years of discovery spirit to uncover therapies that better serve patients.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Pediatric Therapeutics and Diagnostics Solutions sector
3.1 - Buyout funds in the Pediatric Therapeutics and Diagnostics Solutions sector
2.2 - Strategic buyer groups for Pediatric Therapeutics and Diagnostics Solutions sector
4 - Top valuation comps for Pediatric Therapeutics and Diagnostics Solutions companies
4.2 - Public trading comparable groups for Pediatric Therapeutics and Diagnostics Solutions sector
Valuation benchmark group 1: Rare Disease Drug Developers
Novartis
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of innovative medicines and treatments, focusing on the research, development, manufacturing, and marketing of patented pharmaceuticals in areas such as oncology, immunology, cardiovascular, ophthalmology, and neuroscience to improve and extend lives worldwide.
- Key Products:
- Oncology Treatments: Medications for various types of cancer
- Immunology Drugs: Treatments for autoimmune and inflammatory diseases
- Cardiovascular Medicines: Drugs for heart and vascular conditions
- Neuroscience Therapies: Pharmaceuticals for neurological and psychiatric disorders
- Ophthalmology Solutions: Treatments for eye diseases and conditions